Race On To Unlock Value In Genetic Data
How much is your DNA worth? As millions of people pay for home tests to check on ancestry or health risks, genetic data is becoming an increasingly valuable resource for drugmakers, triggering a race to create a DNA marketplace.
Generator Ventures, Focused on the Aging, is Ready to Write Checks
Seed-stage firm Generator Ventures, which is focused entirely on new technologies to serve the country’s aging population, is about to get to work backing startups after graduating its inaugural class of 11 companies from its newly launched accelerator program, investors at the San Francisco-based firm said.
Inflection Points and Reimagination: The State of the Internet, Per Mary Meeker
I just finished plowing through almost all 164 pages of Mary Meeker's annual Internet Trends report. By almost, I mean, not the part about screens and TV, because there are only so many hours in the day, am I right? But I read the rest of it, and now you don't have to (though you may want to, if you have the time). Here are ze key themes...
SAGE Theraputics Nabs $38 Million Series C from OrbiMed Advisors, EcoR1 Capital Management, Foresite Capital Management, Third Rock Ventures, ARCH Venture Partners
“We are impressed by SAGE’s focus on rare and orphan CNS diseases,” said Carl Gordon, Ph.D., CFA, general partner at OrbiMed.